Cellectar Biosciences
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CLRB and other ETFs, options, and stocks.About CLRB
Cellectar Biosciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes CLR 131, which seeks to treat relapse or refractory multiple myeloma, CLR 125, which intends to treat micro metastatic disease, CLR 124, which could detect tumors and metastases in a broad range of cancers, and CLR 1502, a cancer-targeting near-infrared-fluorophore optical imaging PDC for intraoperative tumor and tumor margin illumination.
CLRB Key Statistics
Stock Snapshot
The current Cellectar Biosciences(CLRB) stock price is $2.69, with a market capitalization of 11.7M. The stock trades at a price-to-earnings (P/E) ratio of -0.26.
As of 2026-05-03, Cellectar Biosciences(CLRB) stock has fluctuated between $2.62 and $2.81. The current price stands at $2.69, placing the stock +2.7% above today's low and -4.3% off the high.
Cellectar Biosciences(CLRB) shares are trading with a volume of 36.2K, against a daily average of 19.53K.
During the past year, Cellectar Biosciences(CLRB) stock moved between $2.43 at its lowest and $20.59 at its peak.
During the past year, Cellectar Biosciences(CLRB) stock moved between $2.43 at its lowest and $20.59 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.